Top in allergy/asthma: Tree nut immunotherapy; dupilumab for

Top in allergy/asthma: Tree nut immunotherapy; dupilumab for atopic dermatitis

The safety profile of oral immunotherapy for tree nut allergies among preschoolers was comparable to that of peanut oral immunotherapy, according to recent study results. Stephanie C. Erdle, MD, FRCPC, investigator and allergist at the University of British Columbia, BC Children’s Hospital, and colleagues recommended that tree nut oral immunotherapy (OIT) be offered instead of strict

Related Keywords

United Kingdom , British , Stephaniec Erdle , , University Of British Columbia , Healio Coverage , British Columbia , Clinical Immunology ,

© 2025 Vimarsana